Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Gastritis staging as a clinical priority
Claudia Mescoli1, Aly Gallo Lopez2, Luis Taxa Rojas3
1Surgical Pathology and Cytopathology Unit, Department of Medicine (DIMED), University of Padova.
Gastric cancer risk can be assessed by quantifying stomach lining atrophy. This review evaluates the histology gastritis Operative Link for Gastritis Assessment staging system for personalized gastric cancer risk assessment in patients with gastritis.
Area of Science:
- Gastroenterology and Oncology
- Pathology and Diagnostics
Background:
- Atrophic transformation of the gastric mucosa is a precursor to gastric adenocarcinoma.
- The degree of mucosal atrophy correlates with gastric cancer risk.
- Noninvasive and invasive methods can quantify atrophy to assess individual cancer risk.
Purpose of the Study:
- To review the reliability of the histology gastritis Operative Link for Gastritis Assessment (HGLS) staging system.
- To assess the HGLS system's utility in determining personalized gastric cancer risk.
- To evaluate HGLS for individuals diagnosed with atrophic gastritis.
Main Methods:
- Literature review focusing on studies utilizing the HGLS staging system.
- Analysis of histological assessments of gastric mucosal atrophy.
- Evaluation of correlation between HGLS scores and gastric cancer development.
Main Results:
- The HGLS staging system provides a standardized histological assessment of gastritis.
- Histological assessment of atrophy extent is crucial for risk stratification.
- The reliability of HGLS for personalized risk assessment requires further validation.
Conclusions:
- The HGLS staging system is a valuable tool for assessing gastric mucosal atrophy.
- Accurate staging of gastritis is essential for personalized gastric cancer risk assessment.
- Further research is needed to confirm the predictive accuracy of HGLS for gastric cancer development.
Related Concept Videos
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

